Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The influence of APOE status on cognitive decline

View ORCID ProfileCassandra Morrison, Michael D. Oliver, Virginia Berry, Farooq Kamal, View ORCID ProfileMahsa Dadar
doi: https://doi.org/10.1101/2023.05.23.23290400
Cassandra Morrison
1McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec, H3A 2B4, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, H3A 2B4, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cassandra Morrison
  • For correspondence: Cassandra.morrison{at}mail.mcgill.ca
Michael D. Oliver
3Department of Psychological Science and Neuroscience, Belmont University, Nashville, Tennessee, 37212, United States
4Belmont Data Collaborative, Belmont University, Nashville, Tennessee, 37212, United States
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginia Berry
3Department of Psychological Science and Neuroscience, Belmont University, Nashville, Tennessee, 37212, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farooq Kamal
5Department of Psychiatry, McGill University, Montreal, Quebec, H3A 1A1, Canada
6Douglas Mental Health University Institute, Montreal, Quebec, H4H 1R3, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahsa Dadar
5Department of Psychiatry, McGill University, Montreal, Quebec, H3A 1A1, Canada
6Douglas Mental Health University Institute, Montreal, Quebec, H4H 1R3, Canada
(PhD)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mahsa Dadar
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

INTRODUCTION Apolipoprotein (APOE) ε4 and subjective cognitive decline (SCD) increase risk of Alzheimer’s disease. However, few studies have examined the relationship between SCD and APOE, especially using longitudinal data. The current study examined whether APOE is associated with the rate of cognitive change in SCD.

METHODS Linear mixed effects models examined the relationship between APOE status and cognitive change in older adults with SCD (SCD), normal controls (NC), and people with mild cognitive impairment (MCI).

RESULTS The presence of at least one ε2 allele in SCD and MCI results in cognitive change rates similar to a NC with the ε3ε3 genotype. Older SCD-ε4 individuals exhibited increased cognitive decline compared to all groups, including NC-ε4 and MCI-ε4.

DISCUSSION People with SCD with at least one ε4 allele will experience increased cognitive decline compared to cognitively healthy older adults and people with MCI. These findings have important implications for treatments and interventions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Dr. Morrison is supported by a postdoctoral fellowship from Canadian Institutes of Health Research, Funding Reference Number: MFE-176608. Dr. Kamal is supported by the Quebec Bioimaging Network and Fonds de Recherche du Quebec (FRQS) postdoctoral scholarships. Dr. Dadar reports receiving research funding from the Healthy Brains for Healthy Lives (HBHL), Alzheimer Society Research Program (ASRP), Natural Sciences and Engineering Research Council of Canada (NSERC), Fonds de Recherche du Quebec (FRQS), and Douglas Research Centre (DRC). The RADC/ RUSH cohort studies are supported by the National Institutes of Health, National Institute on Aging (R01 AG17917, R01 AG22018, P30 AG10161, and P30 AG72975).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study used (or will use) ONLY openly available human data that were originally located at: https://www.radc.rush.edu/.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced are available online at https://www.radc.rush.edu/.

https://www.radc.rush.edu/.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted May 28, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The influence of APOE status on cognitive decline
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The influence of APOE status on cognitive decline
Cassandra Morrison, Michael D. Oliver, Virginia Berry, Farooq Kamal, Mahsa Dadar
medRxiv 2023.05.23.23290400; doi: https://doi.org/10.1101/2023.05.23.23290400
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The influence of APOE status on cognitive decline
Cassandra Morrison, Michael D. Oliver, Virginia Berry, Farooq Kamal, Mahsa Dadar
medRxiv 2023.05.23.23290400; doi: https://doi.org/10.1101/2023.05.23.23290400

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Geriatric Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)